April 25, 2008 — /PRWEB/ — SAN JOSE, CA — Enzymes are proteins with highly specialized catalytic functions produced by all living organisms. Enzymes play a major role in various aspects of life and are very important to the existence of life itself. Three-fourths of the ‘bulk’ consumption of enzymes is accounted for in the industries of food, starch processing, and detergent. Specialty enzymes are used in a host of medical applications and diagnostics, including testing of food products.
Asia-Pacific represents the fastest growing market for specialty enzymes, recording a CAGR of over 9 percent in the period 2000 to 2010 as stated by Global Industry Analysts, Inc. The specialty enzymes market in the U.S. is estimated at $1.1 billion. In terms of product segments, the global specialty medical enzymes market is expected to grow at a compounded annual rate of nearly 8.25 percent over the period 2000 to 2010. In Europe, demand for specialty enzymes in pharmaceuticals and diagnostics is projected to be worth $1.0 billion in 2012.
Protein engineering, gene expression, and similar advanced technologies aid in selective screening, modification, and manufacture of enzymes in large quantities. The enzyme market is undergoing a gradual transition from commodity-based to proprietary-based with specialty enzymes supporting novel applications and gradually narrowing down the distinction between industrial and specialty enzymes. Many major companies involved in enzyme production are endeavoring through various avant-garde technologies to progress in this direction. Companies in the biotechnology, chemical, and pharmaceutical industries are actively researching in this direction.
The report titled “Specialty Enzymes: A Global Strategic Business Report,” published by Global Industry Analysts, Inc., provides a review of end-use markets, product overviews, product introductions/innovations, and recent industry activity. The study provides market analytics for the period 2000 to 2015 in value sales for the United States, Canada, Japan, Europe, Asia-Pacific, the Middle East, and Latin America. Product segments discussed include specialty medical enzymes, polymerases, nucleases, and other enzymes. End-use segments discussed are pharmaceuticals and diagnostics and research/biotechnology.
Market participants include Advanced Enzymes Technologies, Amano Enzyme, Aureozyme, Biocon, Biozyme Laboratories, Danisco, Genencor, Kinetic Biosystems, Maxygen, Codexis, Novozymes, Seravac Biotech, Specialty Enzymes and Biochemicals, and Verenium Corporation.